Capricor Therapeutics Inc (CAPR)
6.31
+0.11
(+1.77%)
USD |
NASDAQ |
May 20, 16:00
6.31
0.00 (0.00%)
After-Hours: 19:04
Capricor Therapeutics Total Long Term Debt (Quarterly): 0.00 for March 31, 2024
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | 0.00 |
September 30, 2022 | 0.00 |
June 30, 2022 | 0.00 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.00 |
March 31, 2021 | 0.3182M |
December 31, 2020 | 0.3182M |
September 30, 2020 | 0.3182M |
June 30, 2020 | 0.3182M |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
Date | Value |
---|---|
December 31, 2017 | 0.00 |
September 30, 2017 | 14.16M |
June 30, 2017 | 14.16M |
March 31, 2017 | 13.91M |
December 31, 2016 | 13.91M |
September 30, 2016 | 13.91M |
June 30, 2016 | 12.16M |
March 31, 2016 | 10.16M |
December 31, 2015 | 9.156M |
September 30, 2015 | 9.156M |
June 30, 2015 | 9.156M |
March 31, 2015 | 9.156M |
December 31, 2014 | 9.156M |
September 30, 2014 | 9.156M |
June 30, 2014 | 8.642M |
March 31, 2014 | 3.962M |
December 31, 2013 | 3.962M |
September 30, 2013 | 0.3268M |
June 30, 2013 | 0.2585M |
March 31, 2013 | 0.191M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
0.3182M
Maximum
Jun 2020
0.0636M
Average
--
Median
Jun 2019
Total Long Term Debt (Quarterly) Benchmarks
Sarepta Therapeutics Inc | 1.239B |
PTC Therapeutics Inc | 284.51M |
Solid Biosciences Inc | -- |
Inovio Pharmaceuticals Inc | -- |
Stereotaxis Inc | 0.00 |